{
  "url": "https://www.nasdaq.com/article/cignas-new-plan-to-cover-multimillion-dollar-gene-therapies-20190905-00351",
  "title": "Cigna's new plan to cover multi-million dollar gene therapies - Nasdaq.com",
  "text": [
    "Sept 5 (Reuters) - Health insurer Cigna Corp  on Thursday announced a new program that covers costs for expensive gene therapies that will cut out-of-pocket payments for customers.",
    "Spark Therapeutics Inc  and Novartis AG's  blindness therapy, Luxturna, and Novartis'$2.1 million spinal muscular atrophy treatment, Zolgensma, will be the first two gene therapies included in the program, the company said. ",
    "Sept 5 (Reuters) - Health insurer Cigna Corp  on Thursday announced a new program that covers costs for expensive gene therapies that will cut out-of-pocket payments for customers.",
    "Spark Therapeutics Inc  and Novartis AG's  blindness therapy, Luxturna, and Novartis'$2.1 million spinal muscular atrophy treatment, Zolgensma, will be the first two gene therapies included in the program, the company said. "
  ],
  "published_datetime": "2019-09-05 07:15:00"
}